NHẬN XÉT KẾT QUẢ CHẨN ĐOÁN VÀ ĐIỀU TRỊ VIÊM PHẦN PHỤ TẠI KHOA PHỤ SẢN – BỆNH VIỆN ĐẠI HỌC Y HÀ NỘI

Abstract

Objective: Describe the clinical and paraclinical features and evaluate the treatment outcomes of pelvic inflammatory disease at the Obstetrics and Gynecology Department - Hanoi Medical University Hospital. Subjects and research methods: A cross-sectional descriptive study was conducted on 57 patients diagnosed and treated for pelvic inflammatory disease at the Obstetrics and Gynecology Department from January to June 2024. Results: The study indicates that the majority (70.1%) of patients were between the ages of 21 and 49, and a significant proportion (64.9%) resided in urban areas. Most were married or in a relationship (91.2%). Only 15.8% of patients used condoms. Common clinical symptoms includes abdominal pain (91.2%) and vaginal discharge (77.2%). A total of 63.2% of patients has leukocytes > 10G/L, and high-Sensitivity C-Reactive Protein level was elevated in 87.7% of cases. Ultrasound images often reveal adnexal masses measuring less than 5cm, while MRI and CT scans may show enlarged adnexal structures and fatty infiltration in the pelvic region. 79% of patients were treated medically with a combination regimen of 3 antibiotics (Ceftriaxone, Metronidazole, and Doxycycline); 21% of patients required surgery, mainly due to adnexal abscess. Conclusion: Pelvic inflammatory disease presents with diverse clinical manifestations and needs to be detected and treated early to avoid complications. Internal medical treatment is effective in the majority of cases, while surgery is necessary when internal medical treatments fail or complications arise.